...
首页> 外文期刊>Scandinavian journal of infectious diseases. >Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.
【24h】

Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.

机译:中国上海结核病专科医院的广泛耐药结核病:临床特征和治疗结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Extensively drug-resistant tuberculosis (XDR-TB) has recently emerged as a global public health problem. The objective of this study was to investigate the clinical characteristics, management and outcomes of human immunodeficiency virus-negative patients with XDR-TB at a specialist TB hospital in Shanghai, China. METHODS: From July 2007 to June 2009 we analyzed TB patients with culture-proven XDR-TB at a specialist TB hospital in Shanghai. RESULTS: Among 1156 TB cases, all culture-positive for Mycobacterium tuberculosis complex, 494 cases (42.7%) were classified as MDR-TB; 126 cases (10.9%) were XDR-TB. At least 3 lung fields were involved in 90.5% of XDR-TB patients and in 80.7% of other MDR-TB patients (p = 0.008). Of the XDR-TB cases, 40.5% were complicated by diabetes and other diseases, significantly higher compared with the other MDR-TB cases (p = 0.002). The rates of resistance to all drugs except isoniazid and rifampicin were significantly higher in patients with XDR-TB than in patients with other MDR-TB (p < 0.001). Treatment failure was more common in patients with XDR-TB than in those with other MDR-TB (p < 0.001), whereas the mortality and default rates did not differ significantly. CONCLUSIONS: The prevalence of XDR-TB is high in some areas of China. The clinical treatment outcome for XDR-TB is usually very poor.
机译:背景:广泛耐药结核病(XDR-TB)最近已成为全球公共卫生问题。这项研究的目的是在中国上海一家专门的结核病医院调查人类免疫缺陷病毒阴性的XDR-TB患者的临床特征,管理和结果。方法:从2007年7月至2009年6月,我们在上海一家专业的结核病医院对结核病患者进行了文化验证的XDR-TB分析。结果:在1156 TB病例中,所有结核分枝杆菌复合物的培养阳性,其中494例(42.7%)被归为耐多药结核病。广泛耐药结核病126例(10.9%)。 90.5%的XDR-TB患者和80.7%的其他MDR-TB患者至少涉及3个肺野(p = 0.008)。在广泛耐药结核病例中,有40.5%并发糖尿病和其他疾病,比其他广泛耐药结核病例要高得多(p = 0.002)。 XDR-TB患者对异烟肼和利福平以外的所有药物的耐药率均显着高于其他MDR-TB患者(p <0.001)。 XDR-TB患者的治疗失败比其他MDR-TB患者更常见(p <0.001),但是死亡率和违约率没有显着差异。结论:在中国某些地区,广泛耐药结核的流行率很高。 XDR-TB的临床治疗结果通常很差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号